1. Signaling Pathways
  2. Others
  3. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (10876):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B2132S
    Tryptamine-d2 hydrochloride
    99.87%
    Tryptamine-d2 (hydrochloride) is a deuterium labeled Tryptamine hydrochloride. Tryptamine hydrochloride is a monoamine alkaloid, similar to other trace amines, is believed to play a role as a neuromodulator or neurotransmitter.
    Tryptamine-d<sub>2</sub> hydrochloride
  • HY-Z18070AS
    (Rac)-Ruxolitinib M18 metabolite impurity-d4
    (Rac)-Ruxolitinib M18 metabolite impurity-d4 is the deuterium labeled (Rac)-Ruxolitinib M18 metabolite impurity.
    (Rac)-Ruxolitinib M18 metabolite impurity-d<sub>4</sub>
  • HY-143824S
    Malachite green-d5 (picrate)
    99.00%
    Malachite green-d5 (picrate) is the deuterium labeled Malachite green picrate.
    Malachite green-d<sub>5</sub> (picrate)
  • HY-142119S
    5-Hydroxy tryptophol β-D-glucuronide-d4
    98.0%
    5-Hydroxy tryptophol β-D-glucuronide-d4 is the deuterium labeled 5-Hydroxy tryptophol β-D-glucuronide.
    5-Hydroxy tryptophol β-D-glucuronide-d<sub>4</sub>
  • HY-13273S
    Ostarine-d4
    99.9%
    Ostarine-d4 is a deuterated labeled Ostarine.
    Ostarine-d<sub>4</sub>
  • HY-112499S1
    Menaquinone-7-13C6
    Menaquinone-7-13C6 is the 13C-labeled Menaquinone-7. Menaquinone-7 (Vitamin K2-7), belongs to a class of K2-vitamin homologs, is originally discovered as the anti-hemorrhagic factors. Menaquinone-7 (Vitamin K2-7) is identified as the most bioactive cofactor for the carboxylation reaction of Gla-proteins . Supplementation with Menaquinone-7 (Vitamin K2-7) is a pharmacological option for activating matrix Gla protein and intervening in the progression of calcific aortic valve stenosis (CAVS).
    Menaquinone-7-<sup>13</sup>C<sub>6</sub>
  • HY-I0736S
    Isonicotinic acid-d4
    98.12%
    Isonicotinic acid-d4 is the deuterium labeled Isonicotinic acid (HY-I0736). Isonicotinic acid is an Isoniazid (HY-B0329) metabolite. The Isonicotinic acid derivative Enisamium inhibits the replication of multiple subtypes of influenza A virus.
    Isonicotinic acid-d<sub>4</sub>
  • HY-B0252S1
    Hydrochlorothiazid-13C,d2
    98.64%
    Hydrochlorothiazid-13C,d2 is the 13C- and deuterium labeled Hydrochlorothiazide. Hydrochlorothiazide (HCTZ), an orally active diuretic agent of the thiazide class, inhibits transforming TGF-β/Smad signaling pathway. Hydrochlorothiazide has direct vascular relaxant effects via opening of the calcium-activated potassium (KCA) channel. Hydrochlorothiazide improves cardiac function, reduces fibrosis and has antihypertensive effect.
    Hydrochlorothiazid-<sup>13</sup>C,d<sub>2</sub>
  • HY-B1810S
    Tulobuterol-d9 hydrochloride
    99.0%
    Tulobuterol-d9 (hydrochloride) is the deuterium labeled Tulobuterol. Tulobuterol (C-78 free base) is a long-acting β2-adrenoceptor agonist, which reduces the frequency of exacerbations of chronic obstructive pulmonary disease and bronchial asthma. Tulobuterol is also a sympathomimetic agent used as a transdermal patch, and increases normal diaphragm muscle strength.
    Tulobuterol-d<sub>9</sub> hydrochloride
  • HY-B1028S
    Pantethine-15N2
    Pantethine-15N2 is the 15N2 labeled Pantethine. Pantethine is an orally active lipid-lowering agent. Pantethine has anti-tumor, anti-inflammatory and anti-SARS-COV virus activities. Pantethine is also a neuroprotective agent. Pantethine can be used in the study of Alzheimer's disease, Parkinson's disease, major depression, systemic sclerosis and pantothenate kinase-related neurodegeneration.
    Pantethine-<sup>15</sup>N<sub>2</sub>
  • HY-14182S
    Vernakalant-d6 hydrochloride
    98.95%
    Vernakalant-d6 (hydrochloride) is deuterium labeled Vernakalant.
    Vernakalant-d<sub>6</sub> hydrochloride
  • HY-113308S1
    Taurolithocholic acid-d4
    98.36%
    Taurolithocholic acid-d4 is deuterium labeled Taurolithocholic acid. Taurolithocholic acid is an orally active bile acid and antiviral agent. Taurolithocholic acid upregulates FADS2 by activating the TGR5-PI3K/AKT-SREBP2 signaling axis, inhibits SFTSV-induced ferroptosis, viral replication and viral entry of HBV/HDV, while reducing the release of IL-1β, lipid ROS and LDH. While exerting antiviral protective effects, Taurolithocholic acid also stimulates the recycling of hepatocellular membrane transporters, impairs canalicular bile acid secretion function, and induces hepatocyte cholestasis, apoptosis and acute hepatocellular injury. Taurolithocholic acid serves as an experimental model compound for hepatocellular cholestasis. At concentrations ≤200 μM, Taurolithocholic acid shows no cytotoxicity and does not activate the interferon pathway. Taurolithocholic acid not only protects mice from lethal SFTSV infection but also is suitable for studies related to severe fever with thrombocytopenia syndrome and cholestasis.
    Taurolithocholic acid-d<sub>4</sub>
  • HY-132955S
    Oleoyl-L-carnitine-d3 chloride
    ≥98.0%
    Oleoyl-L-carnitine-d3 (chloride) is the deuterium labeled Oleoyl-L-carnitine chloride.
    Oleoyl-L-carnitine-d<sub>3</sub> chloride
  • HY-N0464S
    Quinic acid-13C3
    99.5%
    Quinic acid-13C3 is the 13C-labeled D-(-)-Quinic acid. D-(-)-Quinic acid scavenges hydrogen peroxide (IC50=87.11 μg/mL) and exhibits antioxidant activity. D-(-)-Quinic acid is the inhibitor for MAO and α-Glucosidase (IC50 =93.75 μg/mL). D-(-)-Quinic acid is orally active.
    Quinic acid-<sup>13</sup>C<sub>3</sub>
  • HY-144140S
    4-Nitroso hydrochlorothiazide-13C,15N2,d2
    99.34%
    4-Nitroso hydrochlorothiazide-13C,15N2,d2 is the deuterium, 13C-, and 15-labeled 4-Nitroso hydrochlorothiazide.
    4-Nitroso hydrochlorothiazide-<sup>13</sup>C,<sup>15</sup>N<sub>2</sub>,d<sub>2</sub>
  • HY-17386S
    Rosiglitazone-d3
    Rosiglitazone-d3 is the deuterium labeled Rosiglitazone. Rosiglitazone (BRL 49653) is a selective, orally active PPARγ agonist with EC50s of 30 nM, 100 nM and 60 nM for PPARγ1, PPARγ2, and PPARγ, respectively. Rosiglitazone binds to PPARγ with a Kd of approximately 40 nM. Rosiglitazone is also an activator of TRPC5 (EC50=~30 μM) and an inhibitor of TRPM3.
    Rosiglitazone-d<sub>3</sub>
  • HY-B0228S12
    Adenosine-d13
    Adenosine-d13 (Adenine riboside-d13; D-Adenosine-d13) is deuterium labeled Adenosine (HY-B0228). Adenosine (Adenine riboside), a ubiquitous endogenous autacoid, acts through the enrollment of four G protein-coupled receptors: A1, A2A, A2B, and A3. Adenosine affects almost all aspects of cellular physiology, including neuronal activity, vascular function, platelet aggregation, and blood cell regulation.
    Adenosine-d<sub>13</sub>
  • HY-113427S
    trans-Vaccenic acid-d13
    trans-Vaccenic acid-d13 is deuterium labeled trans-Vaccenic acid (HY-113427). trans-Vaccenic acid is a naturally occurring trans fatty acid (TFA). trans-Vaccenic acid inhibits nasopharyngeal carcinoma (NPC) cell growth and induces apoptosis through the inhibition of Bad/Akt phosphorylation. trans-Vaccenic acid is a precursor for the synthesis of saturated fatty acid in the rumen and of conjugated Linoleic acid (CLA) at the tissue level. trans-Vaccenic acid exerts hypolipidemic effects in a rat model of obesity.
    trans-Vaccenic acid-d<sub>13</sub>
  • HY-B0389S9
    D-Glucose-13C3-2
    98%
    D-Glucose-13C3-2 is the 13C labeled D-Glucose. D-Glucose (Glucose), a monosaccharide, is an important carbohydrate in biology. D-Glucose is a carbohydrate sweetener and critical components of the general metabolism, and serve as critical signaling molecules in relation to both cellular metabolic status and biotic and abiotic stress response.
    D-Glucose-<sup>13</sup>C<sub>3</sub>-2
  • HY-W011151S
    trans-Zeatinriboside-d5
    99.71%
    trans-Zeatinriboside-d5 is the deuterium labeled trans-Zeatinriboside (HY-W011151). trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits.
    trans-Zeatinriboside-d<sub>5</sub>